Elizabeth McNally, MD, PhD, the Elizabeth J. Ward Professor of Genetic Medicine and director of the Center for Genetic Medicine, has been awarded the 2023 Martin E. and Gertrude G. Walder Award for Research Excellence.
Yobee Care was selected from among our other amazing finalists as co-winners of the 2024 Pitch Slam competitions. They will share in a prize package of business services valued at more than $200,000.
Behavioral health-focused virtual reality company Floreo has acquired Autism Eyes, an autism diagnostic tool developed by Cleveland Clinic Innovations. This news coincides with an announcement that Cleveland Clinic has made a strategic investment in Floreo.
Qral Ventures is excited to spotlight two of our flagship portfolio companies at NU's InQbation Lab Startup Reception, in San Francisco during JPM next week. Dimitra Georganopoulou will be representing Ikaika Therapeutics and Yobee and Paul Bertin will be representing Grove Biopharma
Ikaika Therapeutics is honored to be part of the Hall of Innovations at the Chicago Biomedical Consortium's 2024 BioCapital Symposium.
Our Ikaika team will be represented by our CSO Alexis Demonbreun and our CBO Dimitra Georganopoulou.
MHub, 1817, the Polsky Center and dozens more Chicago tech organizations are seizing the moment during the DNC to show the world what they're working on.
Vijay Ravindran, founder of autism therapy digital therapeutic firm Floreo, spoke to Medtech Insight about working with the FDA, and why the TAP pilot made sense for them.
Yobee Care was selected from among our other amazing finalists as co-winners of the 2024 Pitch Slam competitions. They will share in a prize package of business services valued at more than $200,000.
Winterlight Labs launched AQUA, our automated quality assurance solution for clinical trials, powered by their speech and language technology. AQUA enables quality assurance of clinical assessments and ratings to be conducted more quickly, economically and accurately.
Autism treatment has been a frequent target of private-equity disruption, but it's less common to see a health system's venture arm wade into the space.
Yobee was one of 16 Chicagoland CEOs giving 1-minute elevator pitches on April 2, 2024, at the Start-up Showcase & Board Member Match-up event at the Women in Bio (WIB) - 3.8 Initiative at Portal Innovations, LLC.
Ikaika was one of 16 Chicagoland CEOs giving 1-minute elevator pitches on April 2, 2024, at the Start-up Showcase & Board Member Match-up event at the Women in Bio (WIB) - 3.8 Initiative at Portal Innovations, LLC.
Behavioral health-focused virtual reality company Floreo has acquired Autism Eyes, an autism diagnostic tool developed by Cleveland Clinic Innovations. This news coincides with an announcement that Cleveland Clinic has made a strategic investment in Floreo.
Cambridge Cognition, which acquired Winterlight Labs in 2023, establishes a Scientific Advisory Board comprising experts in cognitive science and clinical trials to guide the integration of emerging trends like blood-based biomarkers and collaborative assessments.
ActiGraph and Cambridge Cognition, leading providers of wearable digital health technologies and CNS assessments, respectively, announced a new strategic partnership to deliver a broad suite of assessments to provide a fully-rounded view of mental and physical capabilities. The companies’ technologies have been used together by top 20 pharma companies in clinical trials already.
mHUB Cuts Ribbon at New Chicago Headquarters and Celebrates Public-Private Collaborations to Accelerate the Commercialization of Transformative Tech for the Physical World
The Chicago Biomedical Consortium showcased promising new biotech innovations at the Chicago BioCapital Summit that took place at Portal Innovations on November 2, 2023, including Ikaika's own CSO Dr. Alexis Demonbreun speaking about Ikaika's anti-fibrotic biologic technology.
Yobee published their second clinical trial with our ScalpMask in pediatrics in Clinical, Cosmetic and Investigational Dermatology, demonstrating that Yobee is safe and effective for kids and adults
Elizabeth McNally, MD, PhD, the Elizabeth J. Ward Professor of Genetic Medicine and director of the Center for Genetic Medicine, has been awarded the 2023 Martin E. and Gertrude G. Walder Award for Research Excellence.
Geneius Biotechnology, Inc., an immuno-oncology company developing a best-in-class personalized RNA-enabled T cell therapy platform for solid and liquid cancers, announced they will present at the upcoming 2023 American Association for Cancer Research (AACR) Annual Meeting.
mHUB, one of the nation’s leading independent hardtech innovation and manufacturing centers, has selected the startup teams that will participate in the premier cohort of its 6-month, hands-on accelerator for high-potential medical device businesses.
England’s Cambridge Cognition has acquired Canadian company Winterlight Labs Inc for £7m to help target a $220 million market for speech-based biomarkers.
mHUB hosted Demo Day events on May 18th & 19th and welcomed investors and industry partners as they met with 9 medtech startups who entered the mHUB Accelerator program last November 2021.
